Medapp

Medapp CapEx Growth

The Year-over-Year CapEx Growth of Medapp (MDA.WA) as of Oct 28, 2026 is -48.07 %. In the previous year, Year-over-Year CapEx Growth was -100.00 % — a change of -51.93% (higher).

CapEx Growth

-48.07 %

YoY

-51.93%

Last updated:

Year-over-Year CapEx Growth of Medapp is 2025 -48.07 % . Year-over-Year CapEx Growth of Medapp was 2024 -100.00 % . It decreases by -51.93% higher compared to the previous year.

The Medapp CapEx Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx Growth
Date
CapEx Growth
Jan 1, 2017
8,460.68 PLN
Jan 1, 2018
-96.22 PLN
Jan 1, 2019
-100.00 PLN
Jan 1, 2021
109.02 PLN
Jan 1, 2022
2,615.42 PLN
Jan 1, 2023
-100.00 PLN
Jan 1, 2025
-48.07 PLN
The Medapp CapEx Growth history
YEARCapEx GrowthYoY
-48.07 %-51.93%
-100.00 %-103.82%
2,615.42 %+2,298.96%
109.02 %-209.02%
-100.00 %+3.93%
-96.22 %-101.14%
8,460.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

Year-over-Year CapEx Growth of Medapp is -48.07 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year CapEx Growth Medapp since 2006 – with annual values, charts, and detailed analysis.

CapEx growth measures the percentage change in capital expenditures. Increasing CapEx can signal investment in future growth capacity.

To evaluate Year-over-Year CapEx Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year CapEx Growth.

Year-over-Year CapEx Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year CapEx Growth's Medapp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Medapp

All Key Metrics — Medapp